Oppenheimer Asset Management Inc. Buys 4,704 Shares of Cigna Group $CI

Key Points

• Oppenheimer Asset Management increased its stake in Cigna (NYSE:CI) by 12.3%, purchasing 4,704 shares to hold 43,024 shares valued at about $11.84 million per its latest 13F filing.
• Cigna beat Q1 expectations (EPS $7.79 vs. $7.60 est.; revenue $68.52B vs. $66.29B), raised its FY‑2026 adjusted EPS guidance to at least $30.35, and declared a quarterly dividend of $1.56 (annualized $6.24, yield ~2.2%).
• The stock carries a consensus analyst rating of "Moderate Buy" with an average price target of $336.20, while several firms (including RBC) have recently raised targets, signaling potential upside.

Oppenheimer Asset Management Inc. boosted its stake in shares of Cigna Group (NYSE:CI - Free Report) by 12.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,024 shares of the health services provider's stock after purchasing an additional 4,704 shares during the quarter. Oppenheimer Asset Management Inc.'s holdings in Cigna Group were worth $11,841,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in CI. Beacon Financial Strategies CORP purchased a new stake in Cigna Group in the fourth quarter valued at about $28,000. Collier Financial purchased a new stake in Cigna Group in the third quarter valued at about $34,000. Lodestone Wealth Management LLC purchased a new stake in Cigna Group in the fourth quarter valued at about $32,000. Activest Wealth Management raised its stake in Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider's stock valued at $38,000 after buying an additional 126 shares during the last quarter. Finally, Founders Capital Management raised its stake in Cigna Group by 53.0% in the third quarter. Founders Capital Management now owns 153 shares of the health services provider's stock valued at $44,000 after buying an additional 53 shares during the last quarter. Institutional investors own 86.99% of the company's stock.

Cigna Group Trading Down 2.6%

Shares of NYSE:CI opened at $283.14 on Friday. The business has a 50-day moving average price of $274.34 and a 200-day moving average price of $276.94. The company has a quick ratio of 0.74, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The stock has a market cap of $74.62 billion, a price-to-earnings ratio of 12.77, a PEG ratio of 1.01 and a beta of 0.26. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to analysts' expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group's quarterly revenue was up 4.6% on a year-over-year basis. During the same period last year, the business earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities analysts predict that Cigna Group will post 30.35 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group's dividend payout ratio (DPR) is currently 28.13%.

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an "outperform" rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Wall Street Analysts Forecast Growth

CI has been the subject of a number of research analyst reports. Zacks Research upgraded Cigna Group from a "strong sell" rating to a "hold" rating in a research note on Monday, January 5th. Raymond James Financial set a $340.00 price objective on Cigna Group in a research note on Friday. Guggenheim restated a "buy" rating and issued a $318.00 price objective on shares of Cigna Group in a research note on Monday, February 2nd. Deutsche Bank Aktiengesellschaft raised their price objective on Cigna Group from $301.00 to $304.00 and gave the stock a "buy" rating in a research note on Tuesday, February 10th. Finally, Robert W. Baird set a $337.00 price objective on Cigna Group in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $336.20.

Insider Activity at Cigna Group

In related news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the firm's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by company insiders.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.